We’re monitoring Thursday’s meeting of the Food and Drug Administration advisory committee that is reviewing the heart-protective data on Vascepa, a drug derived from fish oil that is marketed by Amarin. Check back here often for analysis throughout the day.
Updates will be posted in reverse chronological order.
Hmm cardiologists are against a drug that prevents heart events…
🙂
Can I get these updates by text, how? Thank tou